Mu Xie

No. 7 Xishiku Street
Beijing, 100034, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Uncovering the Secrets of Prostate Cancer's Radiotherapy Resistance: Advances in Mechanism Research.

Uncovering the Secrets of Prostate Cancer's Radiotherapy Resistance: Advances in Mechanism Research.

Journal: Biomedicines

Published: April 16, 2023

Crafting a Personalized Prognostic Model for Malignant Prostate Cancer Patients Using Risk Gene Signatures Discovered through TCGA-PRAD Mining, Machine Learning, and Single-Cell RNA-Sequencing.

Crafting a Personalized Prognostic Model for Malignant Prostate Cancer Patients Using Risk Gene Signatures Discovered through TCGA-PRAD Mining, Machine Learning, and Single-Cell RNA-Sequencing.

Journal: Diagnostics (Basel, Switzerland)

Published: April 09, 2023

Safety and efficacy of radiotherapy combined with chemotherapy for recurrent metastatic renal pelvic and ureteral carcinoma.

Safety and efficacy of radiotherapy combined with chemotherapy for recurrent metastatic renal pelvic and ureteral carcinoma.

Journal: World journal of urology

Published: February 28, 2023

Contouring lumbosacral plexus nerves with MR neurography and MR/CT deformable registration technique.

Contouring lumbosacral plexus nerves with MR neurography and MR/CT deformable registration technique.

Journal: Frontiers in oncology

Published: November 20, 2021

Investigate the Dosimetric and Potential Clinical Benefits Utilizing Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost Technique for Locally Advanced Pancreatic Cancer: A Comparison Between Photon and Proton Beam Therapy.

Investigate the Dosimetric and Potential Clinical Benefits Utilizing Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost Technique for Locally Advanced Pancreatic Cancer: A Comparison Between Photon and Proton Beam Therapy.

Journal: Frontiers in oncology

Published: July 26, 2021

Radiation therapy for nonmetastatic medically inoperable upper-tract urothelial carcinoma.

Radiation therapy for nonmetastatic medically inoperable upper-tract urothelial carcinoma.

Journal: Translational andrology and urology

Published: April 08, 2021

Population-Based Comparison of Different Risk Stratification Systems Among Prostate Cancer Patients.

Population-Based Comparison of Different Risk Stratification Systems Among Prostate Cancer Patients.

Journal: Frontiers in oncology

Published: December 24, 2020

Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3.

Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3.

Journal: Cancer management and research

Published: September 15, 2018

Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study.

Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study.

Journal: OncoTargets and therapy

Published: May 22, 2018

Survival outcomes of radical prostatectomy and external beam radiotherapy in clinically localized high-risk prostate cancer: a population-based, propensity score matched study.

Survival outcomes of radical prostatectomy and external beam radiotherapy in clinically localized high-risk prostate cancer: a population-based, propensity score matched study.

Journal: Cancer management and research

Published: May 19, 2018

The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma.

The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma.

Journal: World journal of surgical oncology

Published: May 13, 2018

BRCA2 mutations should be screened early and routinely as markers of poor prognosis: evidence from 8,988 patients with prostate cancer.

BRCA2 mutations should be screened early and routinely as markers of poor prognosis: evidence from 8,988 patients with prostate cancer.

Journal: Oncotarget

Published: January 23, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026